Guide
NAD+ injections vs NAD+ IV
The IV drip is what the wellness clinics sell; the subcutaneous shot is what a lot of people end up doing at home. This compares the two on the things that actually differ - cost and delivery - and the one thing that does not: the evidence, which is thin for both.
Reviewed 2026-08-21 · 6 sources
Short answer
If you are self-administering, subcutaneous is the accessible, far cheaper route - roughly $40-$290 per injection at a clinic and less on your own, versus $300-$800+ for a single IV session. The IV is faster, fully bioavailable, and supervised, which is worth something for the flush. But neither route has an outcomes trial behind the anti-aging, energy, or addiction claims, so the cost gap is not buying you proven benefit - it is buying you speed and a nurse.
Side by side
| Subcutaneous (self) | IV (clinic) | |
|---|---|---|
| Typical cost | $40-$290 per injection at a clinic; a fraction of that when self-administered from a compounded vial | $300-$800 per session is common ($429-$879 in-clinic by dose), rising to $1,000-$2,000+ for high doses or in major cities |
| Speed & bioavailability | Absorbs over hours; slower, gentler onset | Immediate and complete - straight into the bloodstream, but the most flush-prone if run fast |
| Where and who | At home, self-injected, minimal overhead | In a clinic or IV bar, supervised, with 1-6 hours of chair time |
| Evidence it works | One tolerability preprint dosed NAD+ subq/IM/IV (100 mg x3 days, 4-6 per arm); no outcomes trial | One 8-person pharmacokinetic study (750 mg/6 h) plus a small tolerability pilot; no outcomes trial |
| Product safety | Compounded, not FDA-approved - a Class I recall happened for endotoxin contamination | Same compounded-product risk; supervision helps catch an acute reaction but not a contaminated batch |
The cost gap, in numbers
Clinic pricing pages put a single NAD+ IV session commonly between $300 and $800, with one clinic listing $429 for 250 mg, $549 for 500 mg, and $879 for 1000 mg in-clinic - and mobile or high-dose sessions running past $1,000, up toward $2,000 in major cities. The same clinics quote subcutaneous injections at roughly $40-$290 each. Self-administering from a compounded vial drops the per-dose cost further, which is the whole reason the subcutaneous route exists as a home practice.
Most of the IV premium is not the NAD+ itself - it is the chair time. NAD+ has to be infused slowly to keep the flush bearable, so each session ties up a nurse and a room for one to several hours. To work out your own cost per mg once you have a vial, use the NAD+ reconstitution calculator.
On evidence, the routes are tied at zero
It is tempting to assume the pricier, clinical IV must be better supported. It is not. A 2026 systematic review of 113 studies found no outcomes trials of intravenous or intramuscular NAD+ for anti-aging or wellness at all. The IV route has slightly more human data in one narrow sense - the single pharmacokinetic study used a 6-hour IV infusion - but that study measured blood levels, not benefits. The subcutaneous route shows up only in a small unpublished tolerability preprint. So the honest comparison is: IV is better characterized in the blood, neither is proven to work, and the precursor pills (NR, NMN) that do have trial data are a different molecule that does not transfer to either injection route.
Questions people ask
Is NAD+ IV better than a subcutaneous injection?
There is no head-to-head trial comparing outcomes between the two, so 'better' has no evidence-based answer for the marketed benefits. What differs is the delivery: an IV puts the full dose into your bloodstream immediately under supervision, while a subcutaneous shot absorbs more slowly, costs far less, and can be self-administered. Neither route has an outcomes trial showing it improves energy, slows aging, or treats addiction.
How much does NAD+ IV therapy cost compared to injections?
Clinic pricing pages put a single NAD+ IV session commonly at $300-$800, with in-clinic pricing around $429 for 250 mg, $549 for 500 mg, and $879 for 1000 mg, and high-dose or big-city sessions running past $1,000-$2,000. Subcutaneous injections are quoted at roughly $40-$290 each at a clinic and are cheaper still if you self-administer from a compounded vial. Cost is the clearest difference between the two routes.
Can you inject NAD+ at home instead of getting an IV?
People do - subcutaneous NAD+ is the self-administered route, dosed by volume from a made-up solution. But it is a compounded product with no proven effective dose and no manufacturer safety standard, so sterility and purity are not guaranteed, and the same molecule that causes the IV flush can cause chest tightness and nausea if injected too fast. This is a decision to make with a licensed provider, not on your own.
Why is NAD+ IV so much more expensive?
You are paying for chair time and clinical overhead. NAD+ has to be infused slowly - often over one to several hours - to keep the flush tolerable, which means a nurse, a room, and monitoring for each session. A subcutaneous injection needs none of that, which is most of why it costs a fraction as much.
Sources
- [1]NAD IV Therapy Cost - pricing by dosage, clinic vs mobile (California Infusion Centers)pricingIn-clinic NAD+ IV pricing of roughly $429-$879 per session by dose (250/500/1000 mg), and NAD+ injections quoted at $60-$289. Clinic pricing page, accessed 2026-08-24.
- [2]Cost of NAD IV Therapy - pricing, packages, and what to expect (Omre)pricingNAD+ IV commonly $300-$800 per session (range ~$250-$2,000+), with injections at $40-$200 each. Clinic pricing page, accessed 2026-08-24.
- [3]Grant R, et al. Changes in the Human Plasma and Urine NAD+ Metabolome During a 6 Hour IV Infusion of NAD+. Front Aging Neurosci. 2019 (PMC6751327)studyThe only located human IV-NAD+ pharmacokinetic study (750 mg over 6 hours, n=8); delayed, non-standard kinetics with no half-life derived.
- [4]Gallagher C, Emmanuel OO. NAD+ supplementation for anti-aging and wellness: A PRISMA-guided systematic review of preclinical and clinical evidence. Ageing Res Rev. 2026 PMID 41655607reviewA 2026 systematic review of 113 studies: no outcomes trials evaluated intravenous or intramuscular NAD+ itself for anti-aging or wellness; oral NR and NMN show biochemical target engagement but heterogeneous, often null functional results.
- [5]Nkrumah-Elie Y, et al. Preliminary Safety Analysis of Injections of Nicotinamide Riboside Chloride. medRxiv preprint. 2026studyOne of the only located human trials dosing NAD+ itself via SubQ/IM/IV (100 mg for 3 days, 4-6 subjects per arm); tolerability only, not peer-reviewed.
- [6]FDA Issues Class I Recall for NAD+ Injection Due to Elevated Endotoxin Levels (news, citing FDA enforcement report)regulatoryA real compounded-NAD+ safety incident: a Class I recall for endotoxin contamination after three patients required emergency care.
Pepteca is for education and information only. It does not provide medical advice, diagnosis, or treatment, and its calculators perform unit math only. Always verify with a licensed provider before starting, changing, or stopping any protocol. Many peptides are not approved for human use and may be regulated differently where you live.